Erectile dysfunction and depression: screening and treatment (Q37881309)

24 August 2017

1 reference

title

Erectile dysfunction and depression: screening and treatment (English)

1 reference

24 August 2017

1 reference

Michael A Perelman

1

1 reference

24 August 2017

publication date

1 May 2011

1 reference

Urologic Clinics of North America

24 August 2017

published in

1 reference

24 August 2017

volume

38

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

125-139

1 reference

Prevalence, correlates, and course of minor depression and major depression in the national comorbidity survey

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

The prevalence and influence of significant psychiatric abnormalities in men undergoing comprehensive management of organic erectile dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Psychosocial evaluation and combination treatment of men with erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

"Are you depressed?" Screening for depression in the terminally ill

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Major depression in medically ill patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Epidemiology of comorbid coronary artery disease and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Are platelets the link between depression and ischemic heart disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Depressed mood is related to high-frequency heart rate variability during stressors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Clinical depression and inflammatory risk markers for coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Depression really does hurt your heart: stress, depression, and cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Depression in chronic medical illness: the case of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Increased incidence of depressive symptoms in men with erectile dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Reversible loss of nocturnal penile tumescence during depression: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Nocturnal penile tumescence in depressed men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Diminished nocturnal penile tumescence in depression: a replication study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Sexual function in depressed men. Assessment by self-report, behavioral, and nocturnal penile tumescence measures before and after treatment with cognitive behavior therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Erectile dysfunction and depression: category or dimension?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

The relationship between depression and erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

The dual control model of male sexual response: a theoretical approach to centrally mediated erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Central inhibition of sexual response in the male: a theoretical perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Integrating Sildenafil and Sex Therapy: Unconsummated Marriage Secondary to Erectile Dysfunction and Retarded Ejaculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Psychogenic erectile dysfunction. Classification and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Three-year outcomes for maintenance therapies in recurrent depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Prevalence of sexual dysfunction among newer antidepressants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Sexual dysfunction associated with antidepressant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Tadalafil for treatment of erectile dysfunction in men on antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Sex coaching for physicians: combination treatment for patient and partner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

When an erection alone is not enough: biopsychosocial obstacles to lovemaking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Commentary: pharmacological agents for erectile dysfunction and the human sexual response cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

The PHQ-9: validity of a brief depression severity measure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Is this patient clinically depressed?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Relapse prevention strategies and techniques with erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Accommodation to serotonin reuptake inhibitor-induced sexual dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Evaluation of sexual functioning in depressed outpatients: a double-blind comparison of sustained-release bupropion and sertraline treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Effects of bupropion sustained-release on sexual functioning and nocturnal erections in healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Improvements in SSRI/SNRI-induced sexual dysfunction by switching to escitalopram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Mirtazapine substitution in SSRI-induced sexual dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Imipramine and sexual dysfunction during the long-term treatment of recurrent depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Specific side effects of long-term imipramine management of panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Persistent sexual side effects after SSRI discontinuation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Antidepressant-induced sexual dysfunction and Ginkgo Biloba

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Ginkgo biloba for antidepressant-induced sexual dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Successful treatment of citalopram-induced anorgasmia by cyproheptadine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: A large-scale retrospective study of 596 psychiatric outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Yohimbine in erectile dysfunction: the facts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Depression, antidepressant therapies, and erectile dysfunction: clinical trials of sildenafil citrate (Viagra) in treated and untreated patients with depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Efficacy and safety of sildenafil in men with serotonergic antidepressant-associated erectile dysfunction: results from a randomized, double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Combined pharmacotherapy and psychological treatment for depression: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Are Psychological and Pharmacologic Interventions Equally Effective in the Treatment of Adult Depressive Disorders?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Psychosocial interventions for erectile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

Neurochemical aspects of the sexual response cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Causes of sexual dysfunction: the role of anxiety and cognitive interference

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2011.03.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Epidemiology and neurobiology of female sexual dysfunction

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1111/J.1743-6109.2007.00609.X

Identifiers

DOI

10.1016/J.UCL.2011.03.004

1 reference

24 August 2017

1 reference